ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
about
Guidelines for the diagnosis and management of syncope (version 2009)Complications of cardiac implants: handling device infectionsVagomimetic effects of fingolimod: physiology and clinical implicationsSimulation of Cardiac Arrhythmias Using a 2D Heterogeneous Whole Heart Model2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theA rare variant in MYH6 is associated with high risk of sick sinus syndromeEpidemiology of ventricular tachyarrhythmia : Any changes in the past decades?A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failureLate Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinantsChronic ventricular pacing in children: toward prevention of pacing-induced heart disease.SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study.Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.[What is new in the 2009 ESC guidelines?].[Cardiac syncope : diagnosis and therapy].Rhythm disorders in isolated left ventricular noncompaction.Management of patients with drug-induced atrioventricular block.A primer on arrhythmias in patients with hypertrophic cardiomyopathy.Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication.Implantable cardioverter defibrillators in patients with cardiac amyloidosis.The impact of drug discontinuation in patients treated with temporary pacemaker due to atrioventricular block.Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.Long-term outcomes after event-free cardioverter defibrillator implantation: comparison between patients discharged within 24 h and routinely hospitalized patients in the German DEVICE registry.Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6.Cardiac Evaluation and Monitoring of Patients Undergoing Noncardiac Surgery.Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial.Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres.Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE studyStructural and electrophysiological dysfunctions due to increased endoplasmic reticulum stress in a long-term pacing model using human induced pluripotent stem cell-derived ventricular cardiomyocytes.Inhaled ambient-level traffic-derived particulates decrease cardiac vagal influence and baroreflexes and increase arrhythmia in a rat model of metabolic syndrome.Mortality in patients on renal replacement therapy and permanent cardiac pacemakers.Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials.QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study.Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.Predictive factors for pacemaker requirement after transcatheter aortic valve implantation.Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy.Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.
P2860
Q24622801-85823993-BC70-406A-81F1-3E61C860510AQ26865664-F5220DFD-A48F-47A7-9E23-8786FE0BB989Q27025730-9F6FFC59-85BF-40A6-87B8-F824A2A152C9Q27307949-CB450B52-BA62-4766-B326-19B76F88392AQ28087002-442E1E69-5698-44CE-A927-69B2B79D9821Q28306661-787829E2-3F7F-4A92-A903-CDAEB3C3D988Q30234521-AA999388-8826-4714-857D-BF4FF66FA9EBQ30244099-361F862C-2EA5-4F7E-AD7C-314742EBF773Q30251600-D7A881A9-3906-40D7-AC79-F86C0A492460Q30459704-3C142BBA-DAA2-461A-949D-A3F23CF2189CQ30467327-D55718B9-7509-4F60-B6DE-ADBADC3EFF90Q30475471-7A72C5CE-6D83-4B5F-B6BA-5E8C2CEFCFC9Q30480376-98FE5EA0-80E1-4E77-8528-D5BDC42CC986Q30480484-B1D06ACB-A83C-44A4-9808-3EBE3265D131Q30609810-5396FC1C-0E73-4A86-B450-DEE61648B1C1Q33159974-68E23C7A-8525-4EF7-83EE-AC741B54AED2Q33159994-8B57A59E-C142-48EE-811E-FDB47834355BQ33160113-E2A13FF5-23AB-479F-A9CE-9A7BF34986FBQ33161240-9FBAEA9B-C6A8-4BF5-912A-20D511445FF7Q33161569-4CA542CD-1D68-42AD-8B33-6FBAD8239875Q33161791-D4DF8FC8-A134-48C6-BDA0-F7486087D122Q33162261-3E208663-9A9A-4CFE-8B08-2A45482CAE6BQ33162514-C03CA9EB-3D86-4DE6-A426-B800D6DD9263Q33163054-47FFB6F0-C572-44D7-9972-41976E32DCD4Q33163845-A91A54E1-0386-4DFC-BB52-5C0EDDEDB4C2Q33167353-98F70156-9F2C-4629-9300-CB2AC6246D4FQ33424947-9DF9EEC5-0B96-425B-AF6D-B5156909DBE8Q33583698-0DF67DF0-71C5-4C1F-920E-BE27990A22A8Q33589930-10CE4CAD-7EBC-4EBD-9AD4-6452BBCD4D9DQ33603090-7F934F58-A348-434B-AFFB-7E54B74D22CBQ33631682-FBE8E8BE-21CC-4F85-97A6-E290EE6AE7C9Q33660591-C74E4098-436A-4A31-A234-12BEC2FE9BC5Q33730712-39D1DB6C-04AF-4AEE-8A36-AE62E411B332Q33757747-FF5B0D55-5A99-4A28-8885-C4BFCB51D960Q33974727-BDFE453F-56A9-4855-970C-6E5EEA5273E3Q34228805-B64E02CF-6C28-46DB-9C3D-57407B7017AAQ34237260-73664FA1-64FA-466A-BC76-BD5271D6882AQ34433533-7BE1DFB6-DE10-4702-A702-2BB3BBFC3AA9Q34491469-D952A6F8-259D-4F23-80E1-638AA754DC28Q34544890-6EE09320-24C1-4F16-91A4-82AF02F13ED3
P2860
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
description
article
@en
im Mai 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2008
@uk
name
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
@en
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
@nl
type
label
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
@en
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
@nl
prefLabel
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
@en
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
@nl
P2093
P50
P1476
ACC/AHA/HRS 2008 Guidelines fo ...... d Society of Thoracic Surgeons
@en
P2093
A Marc Gillinov
Alice K Jacobs
American Association for Thoracic Surgery
American College of Cardiology ...... rs and Antiarrhythmia Devices)
Andrew E Epstein
Barbara Riegel
Bruce W Lytle
Christopher E Buller
Clyde W Yancy
Cynthia D Adams
P356
10.1016/J.JACC.2008.02.032
P407
P577
2008-05-01T00:00:00Z